Other
Cytokines
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Cytokines is an early-stage landscape with 0 programs across 1 company. The most active players are AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Completed7 · 64%
Unknown status3 · 27%
Terminated1 · 9%
Clinical Trials
Trial Activity
11 trials
The Efficacy of Symbiotic on Cytokines
Completed·ZZeynep Kamil Maternity and Pediatric Research and Training Hospital·Phase 3·NCT01899677·70 enrolled
Predictive Value of Th1, Th2 and Th17 Cytokines on the Success of Embryo Implantation (ImmuNoFertilité)
Completed·—·N/A·NCT05783349·255 enrolled
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
Completed·—·Phase 4·NCT03990480·230 enrolled
The Changes of Cytokines During Antiviral Therapy
Unknown status·—·N/A·NCT03210506·120 enrolled
The Effects of Escitalopram on Cytokines
Unknown status·—·N/A·NCT01587326·25 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)